Abstract
Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID-19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.
| Original language | English |
|---|---|
| Article number | e05035 |
| Journal | Clinical Case Reports |
| Volume | 9 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- SARS-CoV2 vaccination
- immune thrombocytopenia
- mycophenolate mofetil
- romiplostim
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID-19 vaccination'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver